Anti-Human CD20 Reference Antibody (Ocrelizumab, RUO) (HY257026)

Name: Anti-Human CD20 Reference Antibody (Ocrelizumab, RUO)
Brand: abinScience
SKU: HY257026
Price: 176 USD
Availability: InStock

Datasheet Share product Copy info

Price(USD):

Spec:

100ug
1mg
5mg
10mg
25mg
50mg
100mg

Number:

Get quote

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.	HY257026
Description	Ocrelizumab (HY257026) is a research-grade recombinant antibody targeting CD20. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivity	Human
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species	Human
Isotype	IgG1-nd
Expression system	Mammalian cells
Clonality	Monoclonal
Target	B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20
Endotoxin level	Please contact the lab for this information.
Purity	>95% purity as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	CAS: 637334-45-3
Form	Liquid
Storage buffer	0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Names	2H7, PR-070769/PR070769/R-1594/RG-1594, 637334-45-3
Background	Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes.
Note	For research use only. Not suitable for clinical or therapeutic use.

Images

SEC-HPLC

SEC-HPLC detection for Research Grade Ocrelizumab.
Bioactivity

Detects Human CD20/MS4A1 in indirect ELISAs.
SDS-PAGE

SDS-PAGE for Research Grade Ocrelizumab
Bioactivity

Detected by SAA2631 (Catalog No: AY257013) in indirect ELISA.
Bioactivity

Detected by SAA2632 (Catalog No: AY257023) in indirect ELISA.
Bioactivity

Detected by SAA2633 (Catalog No: AY257033) in indirect ELISA.
Bioactivity

Detected by SAA2634 (Catalog No: AY257034) in indirect ELISA.
Bioactivity

Detected by SAA2746 (Catalog No: AY257053) in indirect ELISA.
Bioactivity

Detected by SAA2747 (Catalog No: AY257063) in indirect ELISA.
Bioactivity

Detected by SAA2748 (Catalog No: AY257073) in indirect ELISA.

References

Datasheet

Anti-Human CD20 Reference Antibody (Ocrelizumab, RUO).pdf

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Recombinant Proteins

Antibodies

Assay Kits

Anti-Human CD20 Reference Antibody (Ocrelizumab, RUO) (HY257026)

Overview

Images

References

Datasheet

SDS

Quick access

Contact Us